Reports for TENOFOVIR DISOPROXIL FUMARATE

Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-TENOFOVIR DISOPROXIL 300MG TABLET Avoided shortage 2022-12-08 2023-02-06 177336
MYLAN-TENOFOVIR DISOPROXIL 300MG TABLET Actual shortage 2025-04-23 2025-09-23 255428
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 300MG 200MG TABLET Resolved 2022-08-15 2022-10-24 166805
PMS-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2025-06-19 2025-06-19 260626
PMS-TENOFOVIR 300MG TABLET Resolved 2024-05-10 2024-10-09 227785
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2020-04-16 2020-05-08 112370
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2022-06-03 2023-02-11 161940
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 300MG 200MG 600MG TABLET Actual shortage 2025-01-23 2025-01-23 248436
TEVA-EMTRICITABINE/TENOFOVIR 200MG 300MG TABLET Resolved 2020-11-06 2021-01-07 128004
TEVA-EMTRICITABINE/TENOFOVIR 300MG 200MG TABLET Resolved 2022-04-21 2023-06-21 159201

Showing 41 to 50 of 53

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260
TEVA-TENOFOVIR 300MG TABLET Discontinued 2025-04-29 2025-04-29 256088

Showing 1 to 2 of 2